“We remain at a standstill for treating bifurcation lesions. The ABS System has the potential to fill that void.”
Roxana Mehran, MD Mount Sinai Hospital New York
“This device is intelligently designed, user friendly and has the potential to improve the treatment of bifurcation lesions.”
Frank Litvack, MD Cedars-Sinai Medical Center Los Angeles
“It is a technically sound and proficient solution to the problem of bifurcation lesions. The technique is simple and the device handles well. With personal clinical experience with the device, the procedure is easy to learn and optimal results are reproducible with impressive coverage of the side branch ostium. Once available, this device should have great commercial potential in the marketplace.”
Sameer Dani, MD Ahmadabad, Gujrat, India
“There is an unmet need for addressing bifurcation lesions. This is the only device that can be used for simple single stent provisional stenting without compromising the need for a possible second stent or a dual stent strategy.”
Saibal Kar, MD Los Robles Health System Thousand Oaks
“Amongst the dedicated stents, ABS is a concept that can be used by all operators in daily clinical practice in the cath lab”
Raj Makar, MD Cedars-Sinai Medical Center Los Angeles
“Bifurcation stenting remains a difficult problem for interventional cardiology. Prior bifurcation systems have been complex and no technique has been shown to be efficacious with low restenosis rates likely due to vessel injury in conjunction with gaps between the stents or overlapping stents. The ABS technology offers, for the first time, an elegant approach that leads to 100% coverage of the complex bifurcation morphology with an easy-to-use system.”
